Abstract:Purpose: To investigate the usefulness of computed tomographic (CT) spectral imaging parameters in differentiating small (<= 3 cm) hepatic hemangioma (HH) from small hepatocellular carcinoma (HCC), with or without cirrhosis, during the late arterial phase (AP) and portal venous phase (PVP).Materials and Methods: This prospective study was institutional review board approved, and written informed consent was obtained from all patients. The authors examined 49 patients (39 men, 10 women; 65 lesions) with CT spectral imaging during the AP and the PVP. Twenty-one patients had HH; nine, HCC with cirrhosis; and 19, HCC without cirrhosis. Iodine concentrations were derived from iodine-based material-decomposition CT images and normalized to the iodine concentration in the aorta. The difference in iodine concentration between the AP and PVP (ie, iodine concentration difference [ICD]) and the lesion-to-normal parenchyma ratio (LNR) were calculated. Two readers qualitatively assessed lesion types on the basis of conventional CT characteristics. Sensitivity and specificity were compared between the qualitative and quantitative studies. The two-sample t test was performed to compare quantitative parameters between HH and HCC.Results: Normalized iodine concentrations (NICs) and LNRs in patients with HH differed significantly from those in patients with HCC and cirrhosis and those in patients with HCC without cirrhosis: Mean NICs were 0.47 mg/mL +/- 0.24 (standard deviation) versus 0.23 mg/mL +/- 0.10 and 0.23 mg/mL +/- 0.08, respectively, during the AP and 0.83 mg/mL +/- 0.38 versus 0.47 mg/mL +/- 0.86 and 0.52 mg/mL +/- 0.11, respectively, during the PVP. Mean LNRs were 5.87 +/- 3.36 versus 2.56 +/- 1.10 and 2.29 +/- 0.87, respectively, during the AP and 2.01 +/- 1.33 versus 0.96 +/- 0.16 and 0.93 +/- 0.26, respectively, during the PVP. The mean ICD for the HH group (1.37 mg/mL +/- 0.84) was significantly higher than the mean ICDs for the HCC-cirrhosis (0.33 mg/mL +/- 0.29) (P < .001) and HCC-no cirrhosis (0.82 mg/mL +/- 0.99) (P = .03) groups. The combination of NIC and LNR had higher sensitivity and specificity compared with those of conventional qualitative CT image analysis during individual and combined phases.Conclusion: Use of spectral CT with fast tube voltage switching may increase the sensitivity for differentiating small hemangiomas from small HCCs in two-phase scanning. (C) RSNA, 2011

Spectral CT Imaging in Differentiation between Focal Nodular Hyperplasia and Hepatocellular Carcinoma

Hepatocellular carcinoma and focal nodular hyperplasia of the liver: differentiation with CT spectral imaging

Values of Spectral CT Imaging in Differential Diagnosis of Hepatocellular Carcinoma and Focal Nodular Hyperplasia

Differentiation of Hepatocellular Carcinoma from Hepatic Hemangioma and Focal Nodular Hyperplasia Using Computed Tomographic Spectral Imaging

Differential Diagnosis of Hepatic Cancerous Nodules and Cirrhosis Nodules by Spectral CT Imaging: a Feasibility Study

Differentiation of Small Hepatic Hemangioma from Small Hepatocellular Carcinoma: Recently Introduced Spectral Ct Method

Clinical value of energy spectrum CT in the differential diagnosis of liver cancer and FNH

The CT Spectral Diagnostic Value in the Diagnosis of Hepatocellular Carcinoma and Angiomyolipoma

Parametric Imaging with Contrast-Enhanced Ultrasound: Usefulness for Characterization of Dynamic Effects of Microvascularization for Hepatocellular Carcinoma and Focal Nodular Hyperplasia.

[Differentiation Between Hyperintense Hepatocellular Carcinoma and Focal Nodular Hyperplasia in Hepatobiliary Phase with Multimodal Parameters of Magnetic Resonance Imaging].

Parametric Imaging with Contrast-Enhanced Ultrasound for Differentiating Hepatocellular Carcinoma from Metastatic Liver Cancer.

Differential Diagnosis Value of Quantitative Color Mapping of the Arterial Enhancement Fraction between Hepatic Focal Nodular Hyperplasia and Hepatocellular Carcinoma

Spectral CT Imaging in Differentiating Pancreatic Carcinoma and Mass-forming Focal Pancreatitis

Diagnosis of the hepatic focal nodular hyperplasia by ultrasonography and CT

Quantitative Analysis of Contrast-Enhanced Ultrasonography: Differentiating Focal Nodular Hyperplasia from Hepatocellular Carcinoma

Plane and Weighted Tri-Phase Helical CT Findings in the Diagnosis of Liver Focal Nodular Hyperplasia.

Evaluation of texture analysis for the differential diagnosis of focal nodular hyperplasia from hepatocellular adenoma on contrast-enhanced CT images

Preliminary Study of Spectral CT Dynamic Contrast-enhanced Imaging on the Diagnosis of Liver Cirrhosis

Spectral Ct: Preliminary Studies In The Liver Cirrhosis

Differentiation of Atypical Hepatocellular Carcinoma from Focal Nodular Hyperplasia: Diagnostic Performance of Contrast-enhanced US and Microflow Imaging.

MSCT Study on Focal Nodular Hyperplasia in Liver